Boon-Cher Goh
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 7
- RNA modifications and cancer 5
- Oncology 30
- Cancer Treatment and Pharmacology 7
- Cancer-related Molecular Pathways 6
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Lingzhi Wang (28 shared papers)Soo Chin Lee (20 shared papers)Nicholas Syn (5 shared papers)Edward Kai‐Hua Chow (2 shared papers)Chwee Teck Lim (1 shared paper)Ross A. Soo (11 shared papers)How-Sung Lee (10 shared papers)Xiaoqiang Xiang (5 shared papers)
- Journals
- Clinical Cancer Research (5 papers)Pharmacogenetics and Genomics (4 papers)Cancers (3 papers)Scientific Reports (2 papers)Therapeutic Drug Monitoring (2 papers)
- Partner nations
- SingaporeChinaUnited States
In The Last Decade
Boon-Cher Goh
57 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 771
- Oncology 978
- Pharmacology 262
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 503
Countries citing papers authored by Boon-Cher Goh
This map shows the geographic impact of Boon-Cher Goh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon-Cher Goh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon-Cher Goh more than expected).
Fields of papers citing papers by Boon-Cher Goh
This network shows the impact of papers produced by Boon-Cher Goh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon-Cher Goh. The network helps show where Boon-Cher Goh may publish in the future.
Co-authors
The 25 scholars most cited alongside Boon-Cher Goh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 355 | |
| 2 | 2002 | 232 | |
| 3 | 2018 | 195 | |
| 4 | 2007 | 114 | |
| 5 | 2015 | 110 | |
| 6 | 2020 | 107 | |
| 7 | 2018 | 104 | |
| 8 | 2020 | 79 | |
| 9 | 2011 | 78 | |
| 10 | 2021 | 75 | |
| 11 | 2008 | 74 | |
| 12 | 2009 | 72 | |
| 13 | 2020 | 66 | |
| 14 | 2008 | 63 | |
| 15 | 2009 | 62 | |
| 16 | 2011 | 59 | |
| 17 | 2022 | 54 | |
| 18 | 2009 | 52 | |
| 19 | 2008 | 52 | |
| 20 | 2018 | 41 |
About Boon-Cher Goh
Boon-Cher Goh is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (7 papers), Cancer-related Molecular Pathways (6 papers), Lung Cancer Treatments and Mutations (6 papers), RNA modifications and cancer (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (771 citations), Oncology (978 citations), Pharmacology (262 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (503 citations). Boon-Cher Goh has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include Lingzhi Wang, Soo Chin Lee, Nicholas Syn, Edward Kai‐Hua Chow, Chwee Teck Lim, Ross A. Soo, How-Sung Lee, Xiaoqiang Xiang, Sing‐Huang Tan and Gautam Sethi. Their work appears in journals such as Clinical Cancer Research, Pharmacogenetics and Genomics, Cancers, Scientific Reports and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.